Sandostatin Lar 30 mg

Sandostatin LAR 30 mg is a sustained-release octreotide acetate powder for suspension, used for long-term management of conditions like acromegaly and certain gastrointestinal disorders. This intramuscular injection is designed to provide extended relief.

Sandostatin LAR 30 mg is primarily used for the long-term management of acromegaly, a condition where the body produces too much growth hormone. It is also used to manage symptoms of certain gastrointestinal disorders, such as diarrhea and flushing associated with carcinoid syndrome. Octreotide acetate works by reducing the production of growth hormones and other substances in the body.

Common effects of Sandostatin LAR 30 mg may include injection site reactions, nausea, vomiting, and abdominal pain. Some users may also experience changes in blood sugar levels, headaches, or fatigue. These effects vary and are not experienced by everyone.

Sandostatin LAR 30 mg should be handled with care, ensuring proper storage and administration by a healthcare professional. It is important to discuss any existing medical conditions or allergies with your healthcare provider before use. Regular monitoring may be required during treatment.

Sandostatin LAR 30 mg may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.